Navigation Links
ADVENTRX Pharmaceuticals to Report Third Quarter 2008 Results
Date:10/30/2008

Conference call scheduled for November 6, 2008 at 1:30 p.m. (Pacific);

simultaneous webcast at http://www.adventrx.com

SAN DIEGO, Oct. 30 /PRNewswire-FirstCall/ -- ADVENTRX Pharmaceuticals, Inc. (Amex: ANX) today announced that it will host a conference call with simultaneous webcast to discuss third quarter 2008 results on Thursday, November 6th, 2008 at 1:30 p.m. Pacific / 4:30 p.m. Eastern. Mark N. K. Bagnall, Executive Vice President and Chief Financial Officer, is scheduled to lead the call and will be joined by other members of the Company's senior management.

The conference call may be accessed by dialing (866) 550-6338 for domestic callers and (347) 284-6930 for international callers, and entering the pass code 1669546. The webcast will be available live via the Internet by accessing ADVENTRX's website at http://www.adventrx.com under "Investors". Replays of the webcast will be available on ADVENTRX's website for 30 days and a phone replay will be available through November 11th, 2008 by dialing (888) 203-1112 and entering the pass code 1669546.

About ADVENTRX Pharmaceuticals

ADVENTRX Pharmaceuticals is a biopharmaceutical company focused on in-licensing, developing and commercializing proprietary product candidates primarily for the treatment of cancer. The Company seeks to improve the performance and commercial potential of existing treatments by addressing problems associated with these treatment regimens. More information can be found on ADVENTRX's web site at http://www.adventrx.com.


'/>"/>
SOURCE ADVENTRX Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. ADVENTRX Pharmaceuticals Reports Second Quarter 2008 Financial Results and Business Update
2. ADVENTRX Pharmaceuticals to Report First Quarter 2008 Results
3. ADVENTRX Pharmaceuticals to Present at The 10th Annual BIO CEO & Investor Conference
4. ADVENTRX Pharmaceuticals to Present at the 2007 RBC Capital Markets Healthcare Conference
5. ADVENTRX Pharmaceuticals to Present at the 13th Annual BIO-Europe Partnering Conference
6. ADVENTRX Pharmaceuticals to Present at the 18th Annual CIBC Healthcare Conference
7. Onyx Pharmaceuticals Announces Third Quarter 2008 Financial Results Teleconference and Webcast
8. PUR Water Filtration Systems Can Remove Pharmaceuticals Identified in U.S. Tap Water - More Than 99 Percent for PUR Faucet Filters and More Than 96 Percent for PUR Pitchers*
9. Morria Biopharmaceuticals Plc Announces Preliminary Results Regarding Inflammatory Markers From its Phase II Study in Allergic Rhinitis
10. Watson Pharmaceuticals Reports Third Quarter 2008 Results
11. Raptor Pharmaceuticals Corp. to Present at Two Upcoming Healthcare Conferences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/16/2017)... ... August 16, 2017 , ... The next Patient Care Academy ... , Students who successfully complete the seven-week long Patient Care Academy are eligible ... The average starting salary for a CNA in Kalamazoo is $24,428.* , As a ...
(Date:8/16/2017)... , ... August 16, 2017 , ... Greenfield Advisors is ... in the U.S. for the second year in a row. The Inc. 5000 list ... three years. , “To be on the list once is a great accomplishment, but ...
(Date:8/16/2017)... ... August 16, 2017 , ... Any Lab Test Now® is thrilled ... on the newly released, 36th annual Inc. 5000 , the most prestigious compilation ... most successful companies within the American economy’s most dynamic segment — its independent small ...
(Date:8/16/2017)... ... 2017 , ... In a recent survey, eighty-two percent of women reported having ... cellulite can't always be eliminated by diet and exercise alone, and now for the ... nationwide. Dr. Kenneth Rothaus has recently added Cellulaze™ to his practice in ...
(Date:8/16/2017)... , ... August 16, 2017 , ... Maury Regional Health ... and blood draws. By broadly deploying AccuVein devices, Maury Regional Medical Center is making ... the guesswork out of a needle stick and more importantly, helps our staff members ...
Breaking Medicine News(10 mins):
(Date:8/1/2017)... , Aug. 1, 2017   CerSci Therapeutics , ... Dallas, Texas , has received notice from the ... Institutes of Health (NIH) that it has been awarded ... totaling over $650,000 in 2017 with an additional $1,000,000 ... Investigational New Drug application of their lead non-opioid drug ...
(Date:7/28/2017)... , July 28, 2017 EnvoyHealth, a Diplomat ... pilot a program for CleverCap LITE, a technology designed ... strives to deliver innovative health technology solutions and services ... CleverCap LITE offers medication ... high-tech bottle cover: ...
(Date:7/26/2017)... Fla. , July 26, 2017 Sancilio ... enrollment of our clinical trial evaluating Altemia TM , ... Anemia (SCA) and Sickle Cell Disease (SCD). The SCOT ... evaluate the efficacy and safety of Altemia TM ... is conducted under US IND 125274. ...
Breaking Medicine Technology: